SylvanCharlesBacaMD

Brigham and Women's Hospital

Dr. Baca is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
75 Francis St
Boston, MA 02115
Phone+1 617-732-5500

Fax+1 617-632-2165

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2017 - 2021
Brigham and Women's HospitalResidency, Internal Medicine, 2015 - 2018
Harvard Medical SchoolClass of 2014

PubMed

1131 citations
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri, Sylvan C. Baca, Michael S. Lawrence, Francesca Demichelis, Mirjam Blattner
Nature Genetics. 2012-06-01
27 citations
H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility.
Claudia Giambartolomei, Ji-Heui Seo, Tommer Schwarz, Malika K. Freund, Ruth Johnson
American Journal of Human Genetics. 2021-11-24
45 citations
ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer.
Shaghayegh Nouruzi, Dwaipayan Ganguli, Nakisa Tabrizian, Maxim Kobelev, Olena Sivak
Nature Communications. 2022-04-27

Precede Biosciences Unveils Groundbreaking Clinical Data for Its Pioneering Liquid Biopsy Platform at ESMO 2023 and Simultaneously Publishes in Nature MedicineOctober 22nd, 2023
Lung, Kidney, and Neuroendocrine Tumor Cancer Studies Led by Dana-Farber Presented at ESMO Congress 2023October 26th, 2023